ACG, an Indian pharmaceutical manufacturer, has inaugurated a new capsule production plant in Rayong, Thailand. The facility is designed to address the growing demand for premium capsules in the region and support ACG’s expansion strategy across Asia. The company expects the new site to enhance supply chain efficiency, shorten delivery times, and serve key markets such as Thailand, Indonesia, Vietnam, South Korea, Malaysia, and the Philippines.
ACG is also seeking approval to supply capsules to China. Spanning over 175,000 square meters, the facility will focus on the production of empty hard gelatin capsules, employing 250 people and boasting an annual production capacity of 20 billion units.
Karan Singh, managing director of ACG, commented, “Thailand has always been a key market for us, and the Rayong facility represents an important step forward in our global growth, following successes in Latin America and North America. With extensive experience in Southeast Asia, we see significant potential in this region.” He added, “By establishing a local presence, we can enhance our capabilities and reduce delivery times, improving operational efficiency and reinforcing our commitment to the Asian market.”
Selwyn Noronha, CEO of ACG Capsules, noted, “The opening of our new unit in Thailand is a strategic move that improves logistics and reduces lead times. This facility meets the highest global manufacturing standards, while also creating local employment opportunities and supporting the region’s growth.”
ACG Group operates in over 100 countries with approximately 4,500 employees worldwide. Earlier this month, the company also announced an expansion of its European operations with an upgrade to its Croatian facility.
